Surgical Science (Q2 Review): Delivering on its promises - Redeye

SUS delivered a strong Q2, beating expectations on both sales and EBIT. Encouragingly, the development with Intuitive continues to be better than feared. The share rallied more than 20% during the day, but we continue to see significant re-rating potential.

Länk till analysen i sin helhet: https://www.redeye.se/research/1180023/surgical-science-q2-review-delivering-on-its-promises?utm_source=finwire&utm_medium=RSS